+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
From
Europe WAYLIVRA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Europe WAYLIVRA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Europe
From
LUCENTIS Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LUCENTIS Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
EYLEA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

EYLEA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Lomitapide Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Lomitapide Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Treprostinil Palmitil Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Treprostinil Palmitil Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Orenitram Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Orenitram Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Treprostinil sodium Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Treprostinil sodium Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
TYVASO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

TYVASO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
PCSK9 Inhibitors (PCSK9i) disease - Epidemiology Forecast - 2032 - Product Thumbnail Image

PCSK9 Inhibitors (PCSK9i) disease - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 140 Pages
  • Global
From
Global ANCA Vasculitis - Pipeline Insight, 2022 - Product Thumbnail Image

Global ANCA Vasculitis - Pipeline Insight, 2022

  • Drug Pipelines
  • August 2022
  • 60 Pages
  • Global
From
From
From
From
Myocarditis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Myocarditis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Heart Failure - Epidemiology forecast- 2032 - Product Thumbnail Image

Heart Failure - Epidemiology forecast- 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hypertrophic Cardiomyopathy (HCM) - Epidemiology forecast- 2032 - Product Thumbnail Image

Hypertrophic Cardiomyopathy (HCM) - Epidemiology forecast- 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Transthyretin Amyloid Cardiomyopathy - Pipeline Inisght, 2021 - Product Thumbnail Image

Transthyretin Amyloid Cardiomyopathy - Pipeline Inisght, 2021

  • Clinical Trials
  • September 2021
  • 60 Pages
  • Global
From
Inclisiran - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Inclisiran - Emerging Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more